Suppr超能文献

病毒适应性、种群复杂性、宿主相互作用以及抗病毒药物的耐药性。

Viral Fitness, Population Complexity, Host Interactions, and Resistance to Antiviral Agents.

机构信息

Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049, Madrid, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029, Madrid, Spain.

出版信息

Curr Top Microbiol Immunol. 2023;439:197-235. doi: 10.1007/978-3-031-15640-3_6.

Abstract

Fitness of viruses has become a standard parameter to quantify their adaptation to a biological environment. Fitness determinations for RNA viruses (and some highly variable DNA viruses) meet with several uncertainties. Of particular interest are those that arise from mutant spectrum complexity, absence of population equilibrium, and internal interactions among components of a mutant spectrum. Here, concepts, fitness measurements, limitations, and current views on experimental viral fitness landscapes are discussed. The effect of viral fitness on resistance to antiviral agents is covered in some detail since it constitutes a widespread problem in antiviral pharmacology, and a challenge for the design of effective antiviral treatments. Recent evidence with hepatitis C virus suggests the operation of mechanisms of antiviral resistance additional to the standard selection of drug-escape mutants. The possibility that high replicative fitness may be the driver of such alternative mechanisms is considered. New broad-spectrum antiviral designs that target viral fitness may curtail the impact of drug-escape mutants in treatment failures. We consider to what extent fitness-related concepts apply to coronaviruses and how they may affect strategies for COVID-19 prevention and treatment.

摘要

病毒的适合度已成为量化其对生物环境适应能力的标准参数。RNA 病毒(和一些高度变异的 DNA 病毒)的适合度测定存在一些不确定性。特别值得关注的是那些源自突变谱复杂性、种群平衡缺失以及突变谱成分内部相互作用的不确定性。本文讨论了实验病毒适合度景观的概念、适合度测量、局限性和当前观点。由于病毒适合度对抗病毒药物耐药性的影响是抗病毒药理学中普遍存在的问题,也是设计有效抗病毒治疗方法的挑战,因此本文详细讨论了这一问题。最近有关丙型肝炎病毒的证据表明,除了标准的药物逃逸突变体选择外,还存在抗病毒耐药的额外机制。考虑到高复制适合度可能是这些替代机制的驱动因素。针对病毒适合度的新型广谱抗病毒设计可能会减少耐药突变体在治疗失败中的影响。我们考虑了适合度相关概念在多大程度上适用于冠状病毒,以及它们可能如何影响 COVID-19 的预防和治疗策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验